Proteome-wide autoantibody screening and holistic autoantigenomic analysis unveil COVID-19 signature of autoantibody landscape - PubMed
6 hours ago
- #Proteome-wide screening
- #Autoantibody
- #COVID-19
- Proteome-wide autoantibody screening and holistic autoantigenomic analysis reveal COVID-19's autoantibody signature.
- Study approved by The University of Tokyo Ethical Committee (Approval numbers 0695 and 2023051G) with informed consent from participants.
- Research conducted under joint contracts with ProteoBridge Corporation and TOKIWA Pharmaceutical Co., Ltd., with disclosed conflicts of interest.
- References include studies on SARS-CoV-2 characteristics, COVID-19 clinical features, and cytokine storm syndromes.